Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Harmen J. van de Werken"'
Autor:
Titia G. Meijer, Luan Nguyen, Arne van Hoeck, Marjolijn M. Ladan, Nicole S. Verkaik, Kirsten Ruigrok-Ritstier, Carolien H. van Deurzen, Harmen J. van de Werken, Esther H. Lips, Sabine C. Linn, Yasin Memari, Helen Davies, Serena Nik-Zainal, Roland Kanaar, John W. Martens, Edwin Cuppen, Agnes Jager, Dik C. van Gent
Publikováno v:
Cancer Research. 82:805-805
Background: Germline BRCA1/2 mutation status is currently used as predictive biomarker for response to Poly-(ADP-Ribose)-Polymerase (PARP) inhibitors in breast cancer (BC) patients. However, non-germline BRCA1/2 mutated tumors and homologous recombin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5bfc096752d7144e30fe18c46e2d3ba0
https://doi.org/10.1158/1538-7445.am2022-805
https://doi.org/10.1158/1538-7445.am2022-805
